After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
Robert F. Kennedy Jr., nominated to be health secretary, seemed unfamiliar with the particulars of the massive insurance ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...
Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback